The neuropsychiatry of movement disorders by Lennox, B

The clinical experience and potential of brain imaging in patients with mental illness. by Lennox, B

Neurocognition of depression by Lennox, B

Neurocognition of depression by Lennox, B

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis by Pollak, T, Lennox, B

Autoimmune encephalitis in the elderly: who to test and what to test for by Behrman, S, Lennox, B

Mind and movement: the neuropsychiatry of movement disorders. by Lennox, B, Lennox, G

Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies by Prüss, H, Lennox, B

Psychotic symptoms in young people warrant urgent referral. by Deakin, J, Lennox, B

Violent outcomes in first-episode psychosis: a clinical cohort study by Whiting, D, Lennox, B, Fazel, S

Discharge pathways and relapse following treatment from early intervention in psychosis services by Puntis, S, Oke, J, Lennox, B

Neuroimmunology 2017: making progress over 20 years by Al-Diwani, A, Lennox, B

Antibody-mediated encephalitis and psychosis. by Pollak, T, Lennox, B, Vincent, A, Nicholson, T

Encephalitis and schizophrenia: a matter of words reply by Lennox, B, Coles, A, Vincent, A

Antibody-mediated encephalitis: a treatable cause of schizophrenia. by Lennox, B, Coles, A, Vincent, A

Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis by Deakin, J, Lennox, B, Zandi, MS

Autoimmune encephalitis: A potentially treatable cause of mental disorder by Rickards, H, Jacob, S, Lennox, B, Nicholson, T

Assessing violence risk in first-episode psychosis: external validation, updating and net benefit of a prediction tool (OxMIV) by Whiting, D, Mallett, S, Lennox, B, Fazel, S

Can prebiotics assist in the management of cognition and weight gain in schizophrenia? by Kao, A, Burnet, P, Lennox, B

Immunopsychiatry in 2021: premise to promise, and back again by Al-Diwani, A, Pillinger, T, Lennox, B